Please see below all current gynaecological cancer clinical trials of the Central Coast Cancer Centre.

Medical Oncology clinical trials

Name: MK 6482

An Open-Label, Multicentre, Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab plus Lenvatinib in Combination with Belutifan in Multiple Solid Tumours.

Principal Investigator: Dr Matthew Wong
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Endometrial Cancer
More information about MK 6482

More information

For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 9890 or see:

 Research and Clinical Trials